Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Lixisenatide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lixisenatide 20micrograms/0.2ml inj 3ml pf dispos dev
0601023AIAAAAAA
|
Lixisenatide | Lixisenatide | Endocrine System | 2,879 |
|
Lyxumia 20micrograms/0.2ml inj 3ml pre-filled pens
0601023AIBBAAAA
|
Lyxumia | Lixisenatide | Endocrine System | 424 |
|
Lixisenatide 10micrograms/0.2ml inj 3ml pf dispos dev
0601023AIAAABAB
|
Lixisenatide | Lixisenatide | Endocrine System | 146 |
|
Lixisenatide 10microg/0.2ml and 20microg/0.2ml inj
0601023AIAAACAC
|
Lixisenatide | Lixisenatide | Endocrine System | 23 |
|
Lyxumia 10micrograms/0.2ml inj 3ml pre-filled pens
0601023AIBBABAB
|
Lyxumia | Lixisenatide | Endocrine System | 13 |
|
Lyxumia 10micrograms/20micrograms treatment initiation pack
0601023AIBBACAC
|
Lyxumia | Lixisenatide | Endocrine System | 1 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.